One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction
Adam D. DeVore, MD, MHS1,2; Bradi B. Granger, PhD, RN3; Gregg C. Fonarow, MD4,5; Hussein R. Al-Khalidi, PhD1; Nancy M. Albert, PhD6; Eldrin F. Lewis, MD, MPH7; Javed Butler, MD, MPH, MBA8; Ileana L. Pi?a, MD, MPH9; Larry A. Allen, MD, MHS10; Clyde W. Yancy, MD11; Lauren B. Cooper, MD, MHS12; G. Michael Felker, MD, MHS1,2; Lisa A. Kaltenbach, MS1; A. Thomas McRae, MD13; David E. Lanfear, MD, MS14; Robert W. Harrison, MD1,2; Maghee Disch, MSN, RN15; Dan Ariely, PhD16; Julie M. Miller, PhD, MSPH16; Christopher B. Granger, MD1,2; Adrian F. Hernandez, MD, MHS1,2
doi : 10.1001/jama.2021.8844
JAMA. 2021;326(4):314-323
Adoption of guideline-directed medical therapy for patients with heart failure is variable. Interventions to improve guideline-directed medical therapy have failed to consistently achieve target metrics, and limited data exist to inform efforts to improve heart failure quality of care.
Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection
Dimitri M. Drekonja, MD, MS1,2; Barbara Trautner, MD, PhD3,4; Carla Amundson, MA1; Michael Kuskowski, PhD2; James R. Johnson, MD1,2
doi : 10.1001/jama.2021.9899
JAMA. 2021;326(4):324-331
Determination of optimal treatment durations for common infectious diseases is an important strategy to preserve antibiotic effectiveness.
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic
Mayte S?nchez van Kammen, MD1; Mirjam R. Heldner, MD, MSc2; Justine Brodard, MSc3; Adrian Scutelnic, MD2; Suzanne Silvis, MD, PhD4; Verena Schroeder, PhD5; Johanna A. Kremer Hovinga, MD3; Saskia Middeldorp, MD, PhD6; Marcel Levi, MD, PhD7,8; Sini Hiltunen, MD, PhD9; Erik Lindgren, MD10,11; Maryam Mansour, MD12; Antonio Arauz, MD, PhD13; Miguel A. Barboza, MD, PhD14; Susanna M. Zuurbier, MD, PhD1; Diana Aguiar de Sousa, MD, PhD15; Jose M. Ferro, MD, PhD15; Urs Fischer, MD, MSc2; Thalia S. Field, MD, MHSc16; Katarina Jood, MD, PhD10,11; Turgut Tatlisumak, MD, PhD10,11; Jukka Putaala, MD, PhD9; Marcel Arnold, MD2; Jonathan M. Coutinho, MD, PhD1
doi : 10.1001/jama.2021.9889
JAMA. 2021;326(4):332-338
Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism.
Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years’ Corrected Age
Nienke M. Halbmeijer, MD1; Wes Onland, PhD1; Filip Cools, PhD2; Renate Swarte, PhD3; Marja van der Heide-Jalving, MD4; Maruschka P. Merkus, PhD5; Anton H. van Kaam, PhD1; for the STOP-BPD Trial Collaborators
doi : 10.1001/jama.2021.9380
JAMA. 2021;326(4):355-357
Lay Epidemiology and Vaccine Acceptance
Sudhakar V. Nuti, MD, MSc1; Katrina Armstrong, MD, MSCE1
doi : 10.1001/jama.2021.11130
JAMA. 2021;326(4):301-302
Potential COVID-19 Endgame Scenarios
Aaron Kofman, MD1; Rami Kantor, MD2; Eli Y. Adashi, MD, MS3
doi : 10.1001/jama.2021.11042
JAMA. 2021;326(4):303-304
The Growing Problem of Out-of-Pocket Costs and Affordability in Employer-Sponsored Insurance
Meredith B. Rosenthal, PhD1
doi : 10.1001/jama.2021.11166
JAMA. 2021;326(4):305-306
The Race We Already Lost
Eileen P. Storey, MD1
doi : 10.1001/jama.2021.11214
JAMA. 2021;326(4):307-308
Shorter Courses of Antibiotics for Urinary Tract Infection in Men
Daniel J. Morgan, MD, MS1,2; K. C. Coffey, MD, MPH1,2
doi : 10.1001/jama.2021.11120
JAMA. 2021;326(4):309-310
Prioritizing Dissemination and Implementation Science in Cardiometabolic Medicine
Ankeet S. Bhatt, MD, MBA1,2; Scott D. Solomon, MD1,2; Muthiah Vaduganathan, MD, MPH1,2
doi : 10.1001/jama.2021.9847
JAMA. 2021;326(4):311-313
Does This Adult Patient Have Hypertension?
Anthony J. Viera, MD, MPH1; Yuichiro Yano, MD, PhD1,2; Feng-Chang Lin, PhD3; David L. Simel, MD4; Jonathan Yun, MD, MPH5; Gaurav Dave, MD, DrPH6; Ann Von Holle, PhD7; Laura A. Viera, MA8; Daichi Shimbo, MD9; Shakia T. Hardy, PhD10; Katrina E. Donahue, MD, MPH11,12; Alan Hinderliter, MD13; Christiane E. Voisin, MSLS12; Daniel E. Jonas, MD, MPH6,12,14
doi : 10.1001/jama.2021.4533
JAMA. 2021;326(4):339-347
Office blood pressure (BP) measurements are not the most accurate method to diagnose hypertension. Home BP monitoring (HBPM) and 24-hour ambulatory BP monitoring (ABPM) are out-of-office alternatives, and ABPM is considered the reference standard for BP assessment.
Anabolic Therapy for Osteoporosis
Kristine E. Ensrud, MD, MPH1,2; John T. Schousboe, MD, PhD3,4
doi : 10.1001/jama.2021.0233
JAMA. 2021;326(4):350-351
Lipoprotein(a) and Cardiovascular Diseases
Hannah Miksenas, BA1; James L. Januzzi Jr, MD1,2; Pradeep Natarajan, MD, MMSc1,2,3
doi : 10.1001/jama.2021.3632
JAMA. 2021;326(4):352-353
Screening for Hepatitis C Virus
Hannah C. Wenger, MD1; Adam S. Cifu, MD2; Arthur Y. Kim, MD1
doi : 10.1001/jama.2020.27041
JAMA. 2021;326(4):348-349
Confronting High HIV Rates Among Transgender Women With Empowerment and Gender Affirmation
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.10598
JAMA. 2021;326(4):295-297
Excess Deaths From End-Stage Kidney Disease Early in Pandemic
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.11312
JAMA. 2021;326(4):300
Resurgence of Pertussis Linked With Switch to Acellular Vaccine
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.11153
JAMA. 2021;326(4):300
Tai Chi Reduces Waist Size Among Older Adults
Anita Slomski
doi : 10.1001/jama.2021.10833
JAMA. 2021;326(4):299
MDMA-Assisted Therapy Highly Effective for PTSD
Anita Slomski
doi : 10.1001/jama.2021.11748
JAMA. 2021;326(4):299
Fewer Cardiovascular Events With Intensive Blood Pressure Control
Anita Slomski
doi : 10.1001/jama.2021.11749
JAMA. 2021;326(4):299
Filgotinib Induces and Maintains Ulcerative Colitis Remission
Anita Slomski
doi : 10.1001/jama.2021.11750
JAMA. 2021;326(4):299
Ending Structural Racism in Federally Funded Research
Rita Rubin, MA
doi : 10.1001/jama.2021.10972
JAMA. 2021;326(4):298
Internet Access as a Social Determinant of Health
Rita Rubin, MA
doi : 10.1001/jama.2021.11733
JAMA. 2021;326(4):298
Higher Medicare Payments for In-home COVID-19 Vaccinations
Rita Rubin, MA
doi : 10.1001/jama.2021.11734
JAMA. 2021;326(4):298
Renal Columns
Zachary David Levy, MD1; Alison Rose Ohringer, MPH, MS2; Bruce Haight, MD3
doi : 10.1001/jama.2021.4061
JAMA. 2021;326(4):294
Cardiac Rehabilitation
Jayson R. Baman, MD1; Shaundeep Sekhon, MD2; Kameswari Maganti, MD1
doi : 10.1001/jama.2021.5952
JAMA. 2021;326(4):366
Effect of Ventral vs Dorsal Spinal Surgery in Patients With Cervical Spondylotic Myelopathy
Hiroyuki Inose, MD, PhD1; Toshitaka Yoshii, MD, PhD2; Atsushi Okawa, MD, PhD2
doi : 10.1001/jama.2021.7262
JAMA. 2021;326(4):357-358
Effect of Ventral vs Dorsal Spinal Surgery in Patients With Cervical Spondylotic Myelopathy
Long Shao, MD, PhD1; Xiang-Dong Wu, MD2; Wei Huang, MD, PhD3
doi : 10.1001/jama.2021.7265
JAMA. 2021;326(4):358
Effect of Ventral vs Dorsal Spinal Surgery in Patients With Cervical Spondylotic Myelopathy—Reply
Zoher Ghogawala, MD1; Fred G. Barker II, MD2; Edward C. Benzel, MD3
doi : 10.1001/jama.2021.7268
JAMA. 2021;326(4):358-359
Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia
Motoharu Shibusawa, MD1; Keisuke Kidoguchi, MD2; Tetsuya Tanimoto, MD3
doi : 10.1001/jama.2021.8151
JAMA. 2021;326(4):359
Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia—Reply
Franco Locatelli, MD1; Gerhard Zugmaier, MD2; Arend von Stackelberg, MD3
doi : 10.1001/jama.2021.8154
JAMA. 2021;326(4):359-360
